Treat your research supplies with the same respect you'd treat surgical instruments
Through the application of PTE and Patent Term Adjustment (PTA), Novo Nordisk succeeded in pushing the expiration of the 343 patent to December 5, 2031
injections of 100 nmol kg 1 GLP-1MK-801 ( n = 8 mice and n = 4 cages), 300 nmol kg 1 GLP-1MK-801 ( n = 8 mice and n = 4 cages) or vehicle (isotonic saline, n = 8 mice and n = 4 cages) for 14 days
Symptoms that require immediate medical attention Fever of 100.4 degrees Fahrenheit or higher
Journal reference: Emptage, I., Kozmr, S., Cobham-Wilson, A., Sousa, B., Sugden, K., Wheeler, L., Llewellyn, C., Makaronidis, J., Bulik, C., Solmi, F
Skin sensitivity and injection site reactions have been reported at rates comparable to other injectable peptides